These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 8149212)

  • 21. The use of botulinum toxin in blepharospasm.
    Shorr N; Seiff SR; Kopelman J
    Am J Ophthalmol; 1985 May; 99(5):542-6. PubMed ID: 4003489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of blepharospasm with botulinum toxin.
    Tsoy EA; Buckley EG; Dutton JJ
    Am J Ophthalmol; 1985 Feb; 99(2):176-9. PubMed ID: 3970122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Palpebral ptosis and blepharospasm secondary to hemispheric cerebral infarction].
    Hijosa M; Esteban A; Sánchez Migallón MJ; Grandas F
    Neurologia; 1998 Jan; 13(1):49-53. PubMed ID: 9522584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum toxin treatment in the facial muscles of humans: evidence of an action in untreated near muscles by peripheral local diffusion.
    Eleopra R; Tugnoli V; Caniatti L; De Grandis D
    Neurology; 1996 Apr; 46(4):1158-60. PubMed ID: 8780112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum toxin improves lid opening delays in blepharospasm-associated apraxia of lid opening.
    Forget R; Tozlovanu V; Iancu A; Boghen D
    Neurology; 2002 Jun; 58(12):1843-6. PubMed ID: 12084888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Botulinum toxin in the management of blepharospasm.
    Dutton JJ; Buckley EG
    Arch Neurol; 1986 Apr; 43(4):380-2. PubMed ID: 3954621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pretarsal injection of botulinum toxin for blepharospasm and apraxia of eyelid opening.
    Jankovic J
    J Neurol Neurosurg Psychiatry; 1996 Jun; 60(6):704. PubMed ID: 8648354
    [No Abstract]   [Full Text] [Related]  

  • 28. Use of botulinum toxin in blepharospasm and other facial spasms.
    Ruusuvaara P; Setälä K
    Acta Ophthalmol (Copenh); 1987 Jun; 65(3):313-9. PubMed ID: 3618155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of blepharospasm with botulinum toxin. A preliminary report.
    Frueh BR; Felt DP; Wojno TH; Musch DC
    Arch Ophthalmol; 1984 Oct; 102(10):1464-8. PubMed ID: 6385932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A case of bilateral blepharospasm responsive to edrophonium].
    Funakawa I; Yasuda T; Katoh H; Hara K; Terao A
    Rinsho Shinkeigaku; 1992 May; 32(5):527-31. PubMed ID: 1458732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The treatment of blepharospasm with botulinum toxin A].
    Költringer P; Haselwander H; Reisecker F
    Wien Klin Wochenschr; 1990 Jul; 102(14):403-7. PubMed ID: 2382447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of treatment with botulinum toxin on neurogenic blepharospasm.
    Elston JS; Russell RW
    Br Med J (Clin Res Ed); 1985 Jun; 290(6485):1857-9. PubMed ID: 3924284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blink recovery in patients with Bell's palsy: a neurophysiological and behavioral longitudinal study.
    VanderWerf F; Reits D; Smit AE; Metselaar M
    Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):203-13. PubMed ID: 17197534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electromyographic evaluation of cervical dystonia for planning of botulinum toxin therapy.
    Dressler D
    Eur J Neurol; 2000 Nov; 7(6):713-8. PubMed ID: 11136361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary blepharospasm: diagnosis and management.
    Defazio G; Livrea P
    Drugs; 2004; 64(3):237-44. PubMed ID: 14871168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of nerve innervation distribution of orbicularis oculi muscle for botulinum neurotoxin application using Sihler's method.
    Çiçek F; Çınaroğlu S; Ceranoğlu FG; Küçük E; Zor KR
    Ann Anat; 2024 Jan; 251():152165. PubMed ID: 37804929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surface electromyographic study of idiopathic cranial dystonia focused on the orbicularis oculi muscles.
    Ohtake T; Hirose K; Tanabe H
    J Neurol Sci; 1992 Jul; 110(1-2):68-72. PubMed ID: 1506871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Botulinum-induced alteration of nerve-muscle interactions in the human orbicularis oculi following treatment for blepharospasm.
    Alderson K; Holds JB; Anderson RL
    Neurology; 1991 Nov; 41(11):1800-5. PubMed ID: 1944912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blepharospasm and related facial movement disorders.
    Patel BC; Anderson RL
    Curr Opin Ophthalmol; 1995 Oct; 6(5):86-99. PubMed ID: 10159723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum A toxin treatment for eyelid spasm, spasmodic torticollis and apraxia of eyelid opening.
    Defazio G; Lepore V; Lamberti P; Livrea P; Ferrari E
    Ital J Neurol Sci; 1990 Jun; 11(3):275-80. PubMed ID: 2387698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.